Moreover, with the support of molecular docking, we demonstrate that bufalin directly binds to BCAT1 and increases the sensitivity of pancreatic cancer cells to gemcitabine and 5-fluorouracil. This evidence concerns the gene BCAT1 and pancreatic neoplasm.